Dundee Corp T.DC.A

Tau Conference from 5-9 March 2024

[TheCount11]

TauRx Pharmaceuticals Ltd., a global leader in Tau-based research in Alzheimer’s disease (AD), announced today that the company will present the 24-month data from its Phase III LUCIDITY trial of hydromethylthionine mesylate (HMTM) at the upcoming AD/PD™ 2024 Alzheimer's & Parkinson's Diseases Conference from 5-9 March 2024, in Lisbon, Portugal.

Look at Dundee stock trade volumes during conference.  March 7 was press release.

Date	Mar 4,2024	Mar 5, 2024	Mar 6, 2024	Mar 7, 2024	Mar 8, 2024
High	0.78	0.84	0.84	0.84	0.89
Low	0.76	0.8	0.8	0.81	0.86
Close	0.78	0.83	0.81	0.82	0.89
vwap	0.773	0.83	0.83	0.82	0.865
volume	19,000	1,724,400	1,328,000	2,261,616	9,500
value	$14,685	$1,431,750	$1,101,980	$1,854,555	$8,215

Notice anything?

[TheCount11]

Is it just me or was there some connection to the expert scientists attending the conference buying Dundee stock hand over fist?  Those volumes are off the charts!

[Macpoor]

Thecount11, I am not sure! But  one thing that I have noticed since 2017 is that the price of DC.A from $8 to .70 cents traded in low volume.  As we saw DC.A was up 9 cents in low volume yesterday! Cheers, Mac

[TheCount11]

Hey Mac! I think of Dundee in TauRx terms now because TauRx 2 yr data is a game changer for a group of patients in the trial.  I think TauRx will change the world.  I wonder what price the company will set the drug at.  I hope TauRx inc is not greedy setting prices.